0001133416-23-000032.txt : 20230130 0001133416-23-000032.hdr.sgml : 20230130 20230130165528 ACCESSION NUMBER: 0001133416-23-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230126 FILED AS OF DATE: 20230130 DATE AS OF CHANGE: 20230130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zordani Richard A. Jr. CENTRAL INDEX KEY: 0001827180 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31791 FILM NUMBER: 23568624 MAIL ADDRESS: STREET 1: 467 N. COUNTRY RIDGE CT. CITY: LAKE ZURICH STATE: IL ZIP: 60047 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC CENTRAL INDEX KEY: 0001133416 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043562325 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD STREET 2: SUITE 240 CITY: NORCROSS STATE: GA ZIP: 30071 BUSINESS PHONE: 678-620-3186 MAIL ADDRESS: STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD STREET 2: SUITE 240 CITY: NORCROSS STATE: GA ZIP: 30071 FORMER COMPANY: FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010612 4 1 form4.xml X0306 4 2023-01-26 0001133416 GALECTIN THERAPEUTICS INC GALT 0001827180 Zordani Richard A. Jr. C/O GALECTIN THERAPEUTICS INC. 4960 PEACHTREE INDUSTRIAL BLVD., STE 240 NORCROSS GA 30071 true Stock Option (right to buy) 1.11 2023-01-26 4 A 0 40000 0 A 2033-01-26 Common Stock 40000 40000 D The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan. The options vest 100% on December 31, 2023. Jack W. Callicutt, by power of attorney 2023-01-30